Investor Relations

Investor Relations

BIOSIG TECHNOLOGIES, INC. DECEMBER CONFERENCE CALL

December 2021

VIEW CONFERENCE CALL TRANSCRIPTClinical Data Unblinding – Transcript

July 2021

Latest News

View All News

Latest Financial Results

Q3 2022

Quarter Ended Sep 30, 2022

Latest Annual Report

View Annual Report

Stock Information

Symbol

Nasdaq: BSGM

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.

Investor Relations

T: (203) 409-5444 x 133
info@biosigtech.com

Transfer Agent

Securities Transfer Corporation
2901 N. Dallas Parkway
Suite 380
Plano, TX 75093
T: (469) 633-0101
F: (469) 633-0088
info@stctransfer.com
www.stctransfer.com

Sign Up for BioSig Updates Contact Us
Twitter linkedin Facebook